Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 3,944 | 0 | 0 | 0 | 0 |
| Cost of Goods | 789 | N/A | N/A | N/A | N/A |
| Gross Profit | 3,155 | N/A | N/A | N/A | N/A |
| Operating Expenses | 12,963 | 8,437 | 8,788 | 11,261 | 10,040 |
| Operating Income | -9,019 | -8,437 | -8,788 | -11,261 | -10,040 |
| Interest Expense | 156 | 96 | 172 | 0 | 0 |
| Other Income | 45 | 53 | 21 | 13 | 23 |
| Pre-tax Income | -9,130 | -8,479 | -8,940 | -11,247 | -10,017 |
| Income Tax | 264 | 264 | 264 | 264 | 264 |
| Net Income Continuous | -9,394 | -8,744 | -9,204 | -11,512 | -10,281 |
| Minority Interests | -1,173 | -784 | -414 | -595 | -513 |
| Net Income | $-8,221 | $-7,959 | $-8,790 | $-10,917 | $-9,768 |
| EPS Basic Total Ops | -0.38 | -0.01 | -0.80 | -1.27 | -1.30 |
| EPS Basic Continuous Ops | -0.44 | -0.04 | -0.84 | -1.34 | -1.37 |
| EPS Diluted Total Ops | -0.38 | -0.01 | -0.80 | -1.27 | -1.30 |
| EPS Diluted Continuous Ops | -0.44 | -0.04 | -0.84 | -1.34 | -1.37 |
| EPS Diluted Before Non-Recurring Items | -0.38 | N/A | -0.80 | -1.27 | -1.30 |
| EBITDA(a) | $-8,462 | $-8,375 | $-8,747 | $-11,205 | $-9,985 |